These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Bevacizumab to Treat Cholangiopathy in Hereditary Hemorrhagic Telangiectasia: Be Cautious: A Case Report. Maestraggi Q; Bouattour M; Toquet S; Jaussaud R; Kianmanesh R; Durand F; Servettaz A Medicine (Baltimore); 2015 Nov; 94(46):e1966. PubMed ID: 26579805 [TBL] [Abstract][Full Text] [Related]
14. Hereditary haemorrhagic telangiectasia: to transplant or not to transplant - is there a right time for liver transplantation? Muller YD; Oppliger R; Breguet R; Meyer P; Rubbia-Brandt L; Petignat PA; Harr T; Dayer E; Seebach JD Liver Int; 2016 Dec; 36(12):1735-1740. PubMed ID: 27864873 [TBL] [Abstract][Full Text] [Related]
15. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. Dupuis-Girod S; Ginon I; Saurin JC; Marion D; Guillot E; Decullier E; Roux A; Carette MF; Gilbert-Dussardier B; Hatron PY; Lacombe P; Lorcerie B; Rivière S; Corre R; Giraud S; Bailly S; Paintaud G; Ternant D; Valette PJ; Plauchu H; Faure F JAMA; 2012 Mar; 307(9):948-55. PubMed ID: 22396517 [TBL] [Abstract][Full Text] [Related]
16. Systemic therapy with bevacizumab in patients with hereditary hemorrhagic telangiectasia (HHT). Chavan A; Schumann-Binarsch S; Luthe L; Nickau B; Elsässer A; Kühnel T; Geisthoff U; Köhne H Vasa; 2013 Mar; 42(2):106-10. PubMed ID: 23485837 [TBL] [Abstract][Full Text] [Related]